Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: Activation of non-store-operated Ca(2+) entry

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Abstract

OBJECTIVE: Sphingosylphosphorylcholine (SPC) is an important lipid mediator that has been implicated in vascular disease. As it has not been studied in the pulmonary circulation, we examined its mechanisms of action in rat small intrapulmonary arteries (IPA). METHODS: IPA were mounted on a myograph for recording tension and intracellular Ca(2+) concentration ([Ca(2+)](i)). Ca(2+) sensitisation was examined in alpha-toxin permeabilized IPA, and by Western blot analysis of MYPT1 phosphorylation. RESULTS: SPC induced a slow but powerful vasoconstriction in IPA associated with an elevation in [Ca(2+)](i), with an EC(50) for vasoconstriction of 12+/-2 muM. Removal of extracellular Ca(2+) increased the EC(50) to 76+/-33 muM (p
Original languageEnglish
Pages (from-to)56 - 64
Number of pages9
JournalCardiovascular Research
Volume68
Issue number1
DOIs
Publication statusPublished - 1 Oct 2005

Fingerprint

Dive into the research topics of 'Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: Activation of non-store-operated Ca(2+) entry'. Together they form a unique fingerprint.

Cite this